Mutares, Closes

Mutares Closes Back-to-Back Transformational Deals, Yet the Share Price Refuses to Budge

Published on 08/06/2026 at 03:12 | Redaktion boerse-global.de

Mutares completes two major acquisitions, including its largest ever, while H1 adjusted EBITDA swings to positive, supporting full-year guidance.

Mutares Acquires SABIC ETP and Magna CTS, Posts Strong H1 Results
Mutares Closes Back-to-Back Transformational Deals, Yet the Share Price Refuses to Budge Illustration mit AI erstellt übermittelt durch boerse-global.de

The Munich-based industrial holding company has spent the past 48 hours reshaping its portfolio at a pace that would exhaust most rivals. On Wednesday, Mutares completed the acquisition of Magna's Car Top Systems (CTS) division, a specialist in roof systems generating roughly €75 million in annual revenue. The business will operate as a standalone unit within the HILO Group's Automotive & Mobility segment. That deal landed just 24 hours after the company finalised the largest acquisition in its history: SABIC's Engineering Thermoplastics (ETP) business, valued at $450 million on an enterprise basis and contributing around $2.5 billion in sales.

The ETP unit, which will now trade under the NexPoint Materials name, forms the cornerstone of a newly created Chemicals & Materials segment. It joins a portfolio that has expanded rapidly in recent months — Mutares had already signed a deal in June to acquire Synthomer a.s. from Synthomer plc, and in July agreed to buy Free2move's carsharing business from Stellantis. The pattern is consistent: large industrial groups shed non-core assets, and Mutares steps in to run them, restructure them, and eventually sell them at a profit.

Earnings Tell a Story of Operational Turnaround

The deal-making frenzy coincided with a half-year report that showed marked improvement on the operating line. Group revenue advanced 9% to €3.4 billion, up from €3.1 billion in the prior-year period. More striking was the swing in adjusted EBITDA, which flipped from a loss of €89 million to a positive €67 million.

The picture at the net level is more nuanced. The holding company's reported net income fell to €6 million from €70 million a year earlier, a decline management attributes to the absence of major exits in the first quarter — a timing effect inherent to the buy-and-sell model Mutares operates. With a strong pipeline of disposals lined up for the second half, the company has left its full-year guidance untouched: it still targets holding-level net profit of €165 million to €200 million, with group revenue expected between €6.7 billion and €7.2 billion.

The secondary source cites a broader revenue range of €7.9 billion to €9.1 billion for 2026, a discrepancy that may reflect differing consolidation assumptions around the newly acquired businesses. Either way, management's confidence rests on closing several pending sales before year-end.

Analyst Stays Bullish Despite Tepid Market Response

Sphene Capital analyst Peter Thilo Hasler reaffirmed his "Buy" rating on the stock following the results, trimming his price target only marginally to €49.30 from €49.40. His rationale centres on the improved quality of operating earnings, as measured by adjusted EBITDA.

Advertisement

As Mutares integrates newly acquired industrial assets, the same discipline applies to managing workplace risks: documenting hazards properly from day one. A free toolkit with 41 ready-to-use templates and checklists helps you stay on top of risk assessments without the paperwork burden. Download the free Risk Assessment Toolkit

The market, however, has yet to share his enthusiasm. The shares closed Wednesday at €26.95, down 0.37%, while the secondary source records a slightly higher price of €27.05, up 0.56% on the day. Whichever quote one uses, the stock sits roughly 23% below its 52-week high of €35.15, reached in mid-January. Year-to-date, the shares are down nearly 10%.

That muted reaction is all the more notable given the regulatory tailwinds. Germany's financial regulator BaFin closed its review of the 2023 annual financial statements without material objections to the management report, requiring only a formal retrospective adjustment regarding the maturity of receivables. Shareholders at the July annual meeting approved a €2.00 per share dividend for fiscal 2025 and appointed PricewaterhouseCoopers as the new auditor for 2026.

Balance Sheet Headroom and a Spring Equity Raise

The acquisition spree has been partly funded by a capital increase completed in early April, when Mutares placed 1,076,166 new shares at €24.50 apiece. Proceeds were earmarked explicitly for portfolio growth — a commitment now visibly fulfilled across the CTS, ETP, and Free2move transactions.

Meanwhile, the company has restored its financial flexibility on the debt side. By June 30, Mutares had regained full compliance with all relevant bond covenants, following the buyback of around €18 million in nominal value of its own Nordic Bonds 2023/2027 in June. The company also completed the acquisition of Nord Gas Solutions on Tuesday, adding an energy-sector asset to the mix.

Investors will have several opportunities in the coming months to gauge whether the newly integrated units are delivering. The half-year earnings call takes place on August 18, followed by the third-quarter update on November 12. A week later, Mutares hosts an Investor Day in London, before appearing at the German Equity Forum in Frankfurt at the end of November.

Whether the operational momentum translates into a sustained share price recovery remains an open question. Much will depend on how quickly the new businesses contribute to the bottom line in the second half — and whether the promised exits materialise to close the gap left by a quiet first quarter.

Advertisement

When integrating new operations, many companies overlook a critical compliance step: documenting hazardous substances properly. A free COSHH toolkit with 43 customisable templates helps you meet your legal duty to assess risks from dangerous materials — saving hours of work. Get the free COSHH Toolkit

Disclaimer...

en | DE000A2NB650 | MUTARES | boerse | 69920832 |